Research in space will use Emulate’s Organs-on-Chips technology to understand changes in the intestinal response to bacterial infection BOSTON–Emulate, Inc. announced today that it has received a research grant to use the company’s Intestine-Chip to conduct experiments that will provide insights into the function of the intestinal barrier and its response to bacterial invasion in microgravity. […]
Cambridge, UK: Horizon Discovery Group plc (AIM: HZD), a global leader in the application of gene editing and gene modulation technologies, today announces that it has entered into an exclusive target discovery partnership with C4X Discovery Holdings plc (AIM: C4XD) (“C4XD”), a pioneering drug discovery company. The partnership aims to validate the novel synthetic lethal oncology […]
VIENNA — Today Lexogen launches a Version 2 (V2) upgrade for the TeloPrime Full-Length cDNA Amplification Kit; an all-in-one protocol for generating 5′ cap-specific full-length cDNA from as little as 1 ng of total RNA. The new TeloPrime V2 Kits provide higher yields and enhanced representation of longer cDNAs than the initial version. Long-read sequencing technologies, […]
Dublin, Ireland – ERS Genomics Limited and Lonza Pharma & Biotech announced today a license agreement to provide Lonza with access to ERS Genomics’ CRISPR/Cas9 genome editing technology patents. Lonza will have the ability to utilize CRISPR/Cas9 in its bioproduction products and services and also for use in induced pluripotent stem cells (iPSC) for research applications. […]
Largest-ever Protein Measurement Study Enhances deCODE’s Efforts in Basic Research, Drug Discovery and Novel Protein-based Diagnostics deCODE genetics, an Amgen subsidiary, and SomaLogic, Inc. today announced a collaboration that brings together SomaLogic’s expertise in human proteins with deCODE’s expertise in human genetics. The collaboration combines deCODE’s rich data sets with SomaLogic’s leading protein measurement capabilities […]
Company will deploy funds to scale its unique targeted single-cell DNA solution for oncology and validation of CRISPR gene editing SOUTH SAN FRANCISCO, Calif. — Mission Bio, Inc., the pioneer in single-cell DNA analysis and precision genomics, today announced it raised $30 million in Series B funding from Agilent Technologies (NYSE: A), Cota Capital, LAM […]
– Potsdam – Oculyze, the world’s premier platform for mobile image analysis and BIOTECON Diagnostics, a renowned food and beverage quality testing provider today announced the signing of a strategic partnership. The agreement signed at the corporate offices of BIOTECON Diagnostics in Potsdam, appoints the Company as the exclusive global distributor of Oculyze’s latest technological […]
Polyplus-transfection® SA, a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction and therapeutics, today announces the launch of jetOPTIMUS®, a new reagent for powerful nanoparticle DNA transfection. “As cell and gene therapies become more advanced and complex, this increases the need to address DNA transfection of very challenging […]
OnRamp’s ROSALIND and Active Motif offer an improved ChIP-Seq data analysis experience for researchers with state-of-the-art dynamics track plots and advanced collaboration capabilities SAN DIEGO — OnRamp BioInformatics, a genomics company focused on scientist-friendly bioinformatics software solutions, today announced they are working with Active Motif to improve accuracies in data analysis for ChIP-Seq experiments. OnRamp’s flagship […]
Berkeley Lights, Inc. and Novo Nordisk today announced that Novo Nordisk has purchased the Beacon®Optofluidic platform to accelerate workflows in cell line development and to use the platform for future protein and antibody discovery. “We are committed to raising the height of our innovation by adopting new technologies that make drug discovery and development more […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
